期刊文献+

虫草素抗三阴性乳腺癌的转录组学分析 被引量:5

RNA-Seq Analysis of Cordycepin Against Triple-negative Breast Cancer
下载PDF
导出
摘要 前期研究表明,蛹虫草活性成分虫草素能有效抑制乳腺癌移植瘤的生长和转移,但其作用机制未清楚。本研究取三阴性乳腺癌移植瘤样品,通过转录组测序技术分析虫草素抗乳腺癌移植瘤的分子作用机制。结果表明,以P<0.05、log2|FC|>1为标准,筛选获得584个差异表达基因,其中上调基因69个,下调基因515个;KEGG分析表明,虫草素对乳腺癌移植瘤的分子调控涉及Hippo signaling pathway、Hedgehog signaling pathway、ECM-receptor interction、TGF-beta signaling pathway等多条癌症相关信号通路;GO分析表明,这些差异基因富集在biological adhesion、growth、metabolic process、locomotion和biological process等16个生物学过程中,提示虫草素对乳腺癌移植瘤生长与转移有极显著的调节作用;进一步对生长和转移过程的基因进行PPI互作分析,提示Hedgehog signaling pathway、Hippo signaling pathway是虫草素抗三阴性乳腺癌的重要潜在作用通路。研究结果提示Hippo-Yap/TAZ信号通路和Hedgehog-Gli信号通路为潜在作用通路,为进一步理解虫草素治疗三阴性乳腺癌的分子机制奠定了基础。 Previous studies have shown that cordycepin,the active ingredient of Cordyceps militaris,can effectively inhibit the growth and metastasis of triple-negative breast cancer xenografts tumor,however its mechanism is not clear yet,thus the purpose of this paper is to predict its mechanism.Taking samples of triple-negative breast cancer xenografts tumor,the molecular mechanism of cordycepin against breast cancer xenografts tumor was analyzed through transcriptome sequencing technology.The results showed that 584 differentially expressed genes were screened using P<0.05,log2|FC|>1 as the standard,including 69 up-regulated genes and 515 down-regulated genes.KEGG analysis demonstrated that cordycepin had molecular regulation on breast cancer xenografts tumors including Hippo signaling pathway,Hedgehog signaling pathway,ECM-receptor interaction,TGF-beta signaling pathway and other cancer-related signaling pathways.GO analysis revealed that these differential genes were enriched in 16 biological processes,such as biological adhesion,growth,metabolic process,and locomotion,etc.It is suggested that cordycepin had significant regulatory effect on the growth and metastasis of breast cancer xenografts tumors.Further protein-protein interaction analysis of these genes in the growth and metastasis process indicated that Hedgehog signaling pathway and Hippo signaling pathway were important potential ones for cordycepin against triple-negative breast cancer.The research results suggest that the Hippo-Yap/TAZ signaling pathway and the Hedgehog-Gli signaling pathway are potential ones,laying the foundation for exploring the molecular mechanism of cordycepin in the treatment of triple-negative breast cancer.
作者 黄海辰 吴文雅 戚梦 薛帆正 吴小平 张君丽 傅俊生 HUANG Hai-chen;WU Wen-ya;QI Meng;XUE Fan-zheng;WU Xiao-ping;ZHANG Jun-li;FU Jun-sheng(College of Life Sciences,Fujian Agriculture and Forestry University,Fuzhou 350002;Mycological Research Center,Fujian Agriculture and Forestry University,Fuzhou 350002;Tibet Academy of Agricultural and Animal Husbandry Sciences,Lhasa 850000)
出处 《生物技术通报》 CAS CSCD 北大核心 2021年第11期72-80,共9页 Biotechnology Bulletin
基金 国家自然科学基金项目(81503187) 特色食用菌种质资源创新研究与菌种繁育关键技术集成示范(XZ202001ZY0041N)。
关键词 虫草素 转录组 三阴性乳腺癌 HEDGEHOG HIPPO cordycepin RNA-Seq triple negative breast cancer Hedgehog Hippo
  • 相关文献

参考文献4

二级参考文献35

  • 1陈彬.医学多因素分析设计样本例数估算——多因素分析设计样本例数综合估算法[J].伤害医学(电子版),2012,1(4):58-60. 被引量:88
  • 2PEROU C M, SORLIE T, EISEN M B, et al. Molecular portraits of human breast tumours [ J ] . Nature, 2000, 406(6797): 747-752.
  • 3BRENTON J D, CAREY L A, AHMED A A, et al. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? [ J ] . J Clin Oncol, 2005, 23(29): 7350-7360.
  • 4GAREY L A, DEES E C, SAWYER L, et al. The triple negative paradox: primary tumor ehemosensitivity of breast cancer subtypes [ J ] . Clin Cancer Res, 2007, 13(8): 2329- 2334.
  • 5FOULKES W D, SMITH I E, REIS-FILHO J S. Triple- negative breast cancer [ J ] . N Engl J Med, 2010, 363(20): 1938-1948.
  • 6DENT R, TRUDEAU M, PRIT(2HARD K I, et al. Triple- negative breast cancer: clinical features and patterns of recurrence [ J ] . Clin Cancer Res, 2007, 13(15 Pt 1): 4429- 4434.
  • 7PRAT A, ADAMO B, CHEANG M C, et al. Molecular characterization of basal-like and non-basal-like triple- negative breast cancer [ J ] . Oncologist, 2013, 18(2): 123- 133.
  • 8GOLDHIRSCH A, WOOD W (2, COATES A S, et al. Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 [ J].Ann Oncol, 2011, 22(8): 1736-1747.
  • 9LEHMANN B D, BAUER J A,DHEN X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies [ J ] . J (21in Invest, 2011,121(7): 2750-2767.
  • 10GUARNERI V, BROGLIO K, KAU S W, et al. Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors [ J ] . J Clin Oneol, 2006, 24(7): 1037-1044.

共引文献70

同被引文献70

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部